Table 1.
Comparison of Strengths and Weaknesses in Epidemiologic and Experimental Animal Studies
| Strengths | Weaknesses | |
|---|---|---|
| Epidemiologic Studies | Examination of exposure/effect relationships in species of interest | Increased potential for exposure and outcome misclassification and confounding |
| Often able to study effects in heterogeneous population | Limited measures of exposure and dose lead to challenges in characterizing quantitative dose-response relationships | |
| Better suited to consider true range of population exposures | Can take longer time to observe effects from exposure | |
| Exposures better reflect temporal nature and delivery mechanism | Relatively more expensive | |
| Evaluate cumulative exposures and health impacts | Confounding exposures/risk factors | |
| Experimental Animal Studies | Allow for examination of full spectrum of toxic effects | Extrapolations required (interspecies, dose, temporal) |
| Facilitates estimation of quantitative dose-response relationships | Dose delivery is artificial and poorly approximates true patterns of exposure | |
| Reduced misclassification of exposures and outcomes | Homogeneity of experimental animals in genetics, lifestage, diet, and initial health state | |
| Study times can be shorter and allow for early indication of harm |